Citadel Advisors’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-27,776
Closed -$136K 7705
2021
Q3
$136K Buy
27,776
+12,649
+84% +$61.9K ﹤0.01% 5661
2021
Q2
$80K Sell
15,127
-27,419
-64% -$145K ﹤0.01% 6055
2021
Q1
$204K Buy
+42,546
New +$204K ﹤0.01% 5394
2020
Q4
Sell
-23,241
Closed -$96K 5836
2020
Q3
$96K Buy
+23,241
New +$96K ﹤0.01% 4262
2020
Q2
Sell
-19,232
Closed -$55K 5550
2020
Q1
$55K Sell
19,232
-21,922
-53% -$62.7K ﹤0.01% 4530
2019
Q4
$155K Buy
41,154
+8,553
+26% +$32.2K ﹤0.01% 4198
2019
Q3
$167K Sell
32,601
-3,991
-11% -$20.4K ﹤0.01% 4163
2019
Q2
$226K Buy
36,592
+11,085
+43% +$68.5K ﹤0.01% 4046
2019
Q1
$181K Sell
25,507
-11,516
-31% -$81.7K ﹤0.01% 3987
2018
Q4
$316K Sell
37,023
-3,343
-8% -$28.5K ﹤0.01% 3553
2018
Q3
$808K Buy
40,366
+12,162
+43% +$243K ﹤0.01% 2862
2018
Q2
$729K Buy
28,204
+8,524
+43% +$220K ﹤0.01% 2898
2018
Q1
$470K Sell
19,680
-273,453
-93% -$6.53M ﹤0.01% 2951
2017
Q4
$9.93M Sell
293,133
-488,432
-62% -$16.6M 0.01% 961
2017
Q3
$16.5M Buy
781,565
+746,937
+2,157% +$15.8M 0.01% 735
2017
Q2
$606K Buy
+34,628
New +$606K ﹤0.01% 2488
2016
Q4
Sell
-13,323
Closed -$219K 4287
2016
Q3
$219K Buy
+13,323
New +$219K ﹤0.01% 3019
2016
Q2
Sell
-108,747
Closed -$1.57M 4088
2016
Q1
$1.57M Sell
108,747
-120,601
-53% -$1.74M ﹤0.01% 1565
2015
Q4
$6.5M Buy
+229,348
New +$6.5M 0.01% 1000
2015
Q3
Sell
-16,341
Closed -$428K 4403
2015
Q2
$428K Sell
16,341
-22,611
-58% -$592K ﹤0.01% 2661
2015
Q1
$682K Sell
38,952
-4,254
-10% -$74.5K ﹤0.01% 2428
2014
Q4
$751K Buy
43,206
+20,475
+90% +$356K ﹤0.01% 2299
2014
Q3
$423K Buy
+22,731
New +$423K ﹤0.01% 2539